Attached files

file filename
EX-31.2 - CERTIFICATION - OptimizeRx Corpf10k2017ex31-2_optimizerx.htm
10-K - ANNUAL REPORT - OptimizeRx Corpf10k2017_optimizerxcorp.htm
EX-31.1 - CERTIFICATION - OptimizeRx Corpf10k2017ex31-1_optimizerx.htm
EX-14.1 - CODE OF BUSINESS CONDUCT AND ETHICS - OptimizeRx Corpf10k2017ex14-1_optimizerx.htm

Exhibit 32.1

 

CERTIFICATION OF CHIEF EXECUTIVE OFFICER AND

CHIEF FINANCIAL OFFICER

PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with the annual Report of OptimizeRx Corp (the “Company”) on Form 10-K for the year ended December 31, 2017 filed with the Securities and Exchange Commission (the “Report”), I, William J. Febbo, Chief Executive Officer of the Company, and I, Douglas P. Baker, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

 

1.The Report fully complies with the requirements of Section 13(a) of the Securities Exchange Act of 1934; and

 

2.The information contained in the Report fairly presents, in all material respects, the consolidated financial condition of the Company as of the dates presented and the consolidated result of operations of the Company for the periods presented.

 

By: /s/ William J. Febbo  
Name: William J. Febbo  
Title: Chief Executive Officer,
Principal Executive Officer
 
Date:

March 8, 2018

 
     
By: /s/ Doug Baker  
Name: Doug Baker  
Title: Chief Financial Officer,
Principal Financial Officer and
Principal Accounting Officer
 
Date:

March 8, 2018

 

 

This certification has been furnished solely pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.